America Is About to Go Over a Peptide Cliff Popular gray-market drugs may soon be easy to get through mainstream channels
BPC-157 has the sequence Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val , molecular weight 1419.6 Da, and CAS registry 137525-51-0
We value your feedback and are committed to providing the best support possible
The safety, tolerance, pharmacokinetic and pharmacodynamic effects of single doses of AT-1001 in coeliac disease subjects: a proof of concept study
Epitalon, in particular, has been linked to increased telomerase activity, which helps slow the aging process
References The USADA or anti-doping agency statement FDA bulletin, Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks PubMed list of papers Also see my newer peptides post that provides more context on peptides and compounding as well as FDA oversight along with political impacts